The Partnership to Advance Clinical electronic Research (PACeR)
The goal of the Partnership to Advance Clinical electronic Research (PACeR) is to increase the speed, quality, and efficacy of clinical studies, helping to provide patients with quicker access to new treatments and life-saving medicines.
PACeR aims to achieve this goal by designing and launching an economically sustainable, electronic clinical research data network in New York State to more efficiently identify potential candidates for clinical research trials and manage their care.
Benefits for Many Stakeholders
- Patients: PACeR will accelerate the process of bringing innovative medicines to the public.
- Academic Medical Centers, Community Hospitals, Principal Investigators, and Other Scientists: PACeR will provide a roadmap for conducting medical research and improving patient care.
- The Research Community: Timely analysis of large amounts of high-quality clinical care data will streamline the clinical trial protocol development process.
- Health Information Technology Companies: PACeR will develop functional specifications for software to meet the needs of scientific, evidence-based research, in addition to observational research and financial analysis.
- Regulators: Access to improved data and analysis will support safety surveillance initiatives and causal analysis of adverse events.
- Public/Private Initiatives Such as RHIOs: PACeR offers a mechanism for clinical data nomenclature standardization and interoperability across hospitals and physician networks.
- New York State: PACeR will enhance the state's position as a center for medical research and home to some of the world's most prominent academic medical centers, and ensure that it captures a greater share of strategic investment in clinical research.
What PACeR Will Achieve
PACeR will deliver significant benefits for patients, providers, and other health care sector participants, including:
- Accelerating the process of delivering new medicines to patients
- Improving the efficiency and efficacy of research conducted by academic medical centers
- Improving the ability of information technology companies to understand patient and provider needs, resulting in enhanced system offerings
- Increasing the return on investment for pharmaceutical research resources
- Augmenting New York State's unique position as the global epicenter for medical research
Information and Press
A Broad-Based Health Care Collaborative
to Provide the Next Generation of Clinical
Research for New Medicines
Download Full Press Release